"There is no better place than Genentech where collaborating with colleagues to develop innovative therapeutics for patients is so inspiring and fun."
I joined the Department of Infectious Diseases at Genentech (called the Department of Microbial Pathogenesis at the time) as a Scientist in 2007. Primarily trained in Virology and Immunology, we were initially tasked with establishing an anti-Hepatitis C Virus (HCV) program. Since then, we have been focused on better understanding bacterial pathogenesis and biology in order to identify novel targets for therapeutic intervention.
What initially attracted me to Genentech and still keeps me engaged to this day is the unrelenting collaborative and unselfish nature of the scientists whom I have the privilege of working with every day. In addition, a solid research infrastructure and commitment to rigorous science pushes me to uncover transformative biology that could help the development of better and safer therapies for patients.
I have been very lucky to have been trained by truly outstanding scientists and mentors during my training as an undergraduate, graduate and postdoctoral fellow, and these experiences have made me really appreciate the value of a good mentor and how they can shape the way a scientist thinks once they move on to their independent career. Being a postdoc mentor is a very rewarding experience for me and I hope to transfer some of the knowledge and experiences I learned as a trainee to the next generation of scientists and drug discoverers.
MBio. 2017 May 23;8(3). pii: e00603-17.
Our group is very interested in bacterial lipoprotein biosynthesis and transport, immune-mediated mechanisms of bacterial clearance in the lung and gaining further insight into mechanisms of bacterial escape from immune as well as antibacterial clearance. We use a wide variety of genetic, cellular and biochemical methods to uncover novel host-pathogen interactions that could lead to the development of new therapeutics intervention strategies.